Nasopharyngeal Carcinoma Treatment Market 2021 Future Growth Prospect, Industry Report And Growing Demand Analysis Till 2027
The Nasopharyngeal Carcinoma Treatment Market analysis report speaks about the growth rate till 2027 manufacturing process, Growth, key factors driving this market with sales, revenue, and price analysis of lead manufacturers, distributors, traders and dealers of Nasopharyngeal Carcinoma Treatment.
Coherent Market Insights always aims at offering their clients an in-depth analysis and the best research of the various market. The “Nasopharyngeal Carcinoma Treatment Market projected to develop with growing expansion prospects”. The Nasopharyngeal Carcinoma Treatment Market report presents a calculated opinion of the analyzed Nasopharyngeal Carcinoma Treatment Market data. It explains various opportunities dedicated to different industries, suppliers, organizations, and associations offering various products and services such as offering them precise guidance for their expansion in the competition for reliable services to consumers.
Nasopharyngeal carcinoma is a rare type of cancer that affects pharynx, the part of throat which is connected to nose and mouth. The early stage symptoms of nasopharyngeal carcinoma include blockage and stuffiness in nose, bleeding nose, hearing difficulties, persistent ear infection, and sore throat and the late stage symptoms are bulging eye, weight loss, and others.
X-ray, EBV antibody test, endoscopy, CT scan, MRI, ultrasound, biopsy, PET scan or PET-CT scan are different diagnostic tools for detecting nasopharyngeal cancers. The main treatment for nasopharyngeal carcinoma includes radiation therapy or chemotherapy, and combination of both the therapies, known as concomitant chemotherapy. According to American Institute of Cancer Research, nasopharyngeal cancer is the 23rd most common cancer worldwide and the 22nd most commonly occurring cancer in the world. As per the same source, approximately 129,000 new cases of nasopharyngeal cancer were reported globally in 2018. Thus, increasing number of cases of nasopharyngeal cancer is expected to drive the global nasopharyngeal carcinoma treatment market.
The prominent players in the Nasopharyngeal Carcinoma Treatment Market are Pfizer Inc., Sanofi, Merck & Co., Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., and Fresenius SE & Co. KGaA.
Buy This Complete A Business Report With Flat US $2000 Off @
Increasing incidence of nasopharyngeal cancer is anticipated to drive the growth of the nasopharyngeal carcinoma treatment market during the forecast period (2018-2026). According to International Agency for Research on Cancer, Brunei had the highest rate of nasopharyngeal cancer in 2018 followed by Maldives and Singapore. According to Canadian Cancer Society’s statistics 2013, 240 Canadians were diagnosed with nasopharyngeal cancer every year whereas, 102 die due to nasopharyngeal cancer every year.
Ongoing Research studies conducted by researchers and healthcare providers to develop better treatment option, is further anticipated to boost the growth of the nasopharyngeal carcinoma treatment market. Taiho Pharmaceutical, a Japan-based pharmaceutical company, is mainly focused on developing innovative and highly valuable cancer drugs such as S-1 and valproic acid which shows promising potential to treat head and neck cancer.
Moreover, increasing popularity of targeted therapies such as tyrosine kinase inhibitors (dacomitinib, gefitinib, afatinib, erlotinib and lapatinib), monoclonal antibodies (panitumumab), phosphoinositide 3-kinase inhibitors (PX-866 and buparlisib), and others for the treatment of cancers is expected to boost the market growth in the near future.
On the basis of region, the global nasopharyngeal carcinoma treatment market is divided into North America, Latin America, Europe, Middle East, Asia Pacific, and Africa. Among region, North America is expected to hold dominant position in the nasopharyngeal carcinoma treatment market during the forecast period, owing to increasing research and development activities by key market players in the region for developing better cancer therapeutics.
However, Asia Pacific is estimated to be fastest growing hypo-pharyngeal cancer treatment market owing to increasing incidence of nasopharyngeal carcinoma in the region. According to Union for International Cancer Control 2014, in APAC region especially in Southern China and Southeast Asia, the annual age-standardized incidence rates are as high as 20 to 30 cases per 100,000 population in men and 8 to 15 cases per 100,000 populations in women. According to article published in World Cancer Research Journal, in 2012, there were 42,100 cases of nasopharyngeal cancer reported in China, 13,084 cases in Indonesia, 4,931 cases in Vietnam, 3,947 in India, and 2,030 in Malaysia.
Main points in Nasopharyngeal Carcinoma Treatment Market Report Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Nasopharyngeal Carcinoma Treatment Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Nasopharyngeal Carcinoma Treatment Industry Impact
Chapter 2 Global Nasopharyngeal Carcinoma Treatment Competition by Types, Applications, and Top Regions and Countries
2.1 Global Nasopharyngeal Carcinoma Treatment (Volume and Value) by Type
2.3 Global Nasopharyngeal Carcinoma Treatment (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Nasopharyngeal Carcinoma Treatment Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Nasopharyngeal Carcinoma Treatment Market Analysis
Chapter 6 East Asia Nasopharyngeal Carcinoma Treatment Market Analysis
Chapter 7 Europe Nasopharyngeal Carcinoma Treatment Market Analysis
Chapter 8 South Asia Nasopharyngeal Carcinoma Treatment Market Analysis
Chapter 9 Southeast Asia Nasopharyngeal Carcinoma Treatment Market Analysis
Chapter 10 Middle East Nasopharyngeal Carcinoma Treatment Market Analysis
Chapter 11 Africa Nasopharyngeal Carcinoma Treatment Market Analysis
Chapter 12 Oceania Nasopharyngeal Carcinoma Treatment Market Analysis
Chapter 13 South America Nasopharyngeal Carcinoma Treatment Market Analysis
Chapter 14 Company Profiles and Key Figures in Nasopharyngeal Carcinoma Treatment Business
Chapter 15 Global Nasopharyngeal Carcinoma Treatment Market Forecast (2021-2027)
Chapter 16 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
- CDN Newswire